Physician profile
Bruni Leka
NPI 1689014425
$734.45
in general payments reported to CMS, 2019-2025
12 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $18.83 · 2021: $71.43 · 2022: $16.80 · 2023: $84.00 · 2024: $188 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $249.50 | 2019-2024 | Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $213.11 | 2023-2025 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $71.43 | 2021 | |
| International Rehabilitative Sciences, INC | $39.93 | 2023 | Rs 4i Plus Sequential Stimulator |
| Reprise Biomedical, INC. | $33.03 | 2024 | Miro3d |
| Next Science LLC | $24.43 | 2025 | Blastx, Xperience |
| Solventum Corporation | $20.50 | 2025 | Promogran Prisma, Activ.A.C. |
| Averitas Pharma INC. | $20.46 | 2025 | Qutenza |
| Organogenesis INC. | $18.83 | 2020 | |
| Grt US Holding, INC. | $16.80 | 2022 | |
| Orthofix Medical, INC. | $15.33 | 2025 | Physio-Stim |
| Merck Sharp & Dohme LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruni Leka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.